Total Payments
$9,964
2024 Payments
$2,770
Companies
35
Transactions
489
Medicare Patients
3,055
Medicare Billing
$707,208
Payment Breakdown by Category
Food & Beverage$9,813 (98.5%)
Education$100.99 (1.0%)
Travel$50.00 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,813 | 486 | 98.5% |
| Education | $100.99 | 2 | 1.0% |
| Travel and Lodging | $50.00 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,284 | 114 | $0 (2024) |
| Amgen Inc. | $2,219 | 126 | $0 (2024) |
| Lilly USA, LLC | $775.52 | 22 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $572.25 | 28 | $0 (2024) |
| Janssen Biotech, Inc. | $560.02 | 27 | $0 (2024) |
| UCB, Inc. | $550.11 | 27 | $0 (2024) |
| GlaxoSmithKline, LLC. | $549.86 | 22 | $0 (2024) |
| PFIZER INC. | $345.84 | 15 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $257.77 | 13 | $0 (2024) |
| Horizon Therapeutics plc | $236.21 | 11 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,770 | 127 | Amgen Inc. ($532.57) |
| 2023 | $2,184 | 97 | AbbVie Inc. ($927.71) |
| 2022 | $2,549 | 129 | ABBVIE INC. ($604.96) |
| 2021 | $626.42 | 37 | Amgen Inc. ($319.80) |
| 2020 | $708.32 | 42 | Amgen Inc. ($273.17) |
| 2019 | $1,001 | 56 | Amgen Inc. ($245.91) |
| 2018 | $125.00 | 1 | Genentech USA, Inc. ($125.00) |
All Payment Transactions
489 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $5.05 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Endocrinology | ||||||
| 11/19/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Fidia Pharma USA Inc. | HYMOVIS (Device), HYALGAN, TRILURON | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: OSTEOARTHRITIS | ||||||
| 11/06/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/05/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $8.46 | General |
| Category: Inflammation | ||||||
| 11/04/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $33.09 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $33.59 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: Immunology | ||||||
| 10/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $8.88 | General |
| Category: Immunology | ||||||
| 10/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $8.69 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Endocrinology | ||||||
| 10/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.14 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $30.71 | General |
| Category: Immunology | ||||||
| 09/25/2024 | Fresenius Kabi USA, LLC | — | Food and Beverage | In-kind items and services | $27.09 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 774 | 8,722 | $946,863 | $259,033 |
| 2022 | 15 | 698 | 4,874 | $577,506 | $163,859 |
| 2021 | 15 | 667 | 2,637 | $283,747 | $114,174 |
| 2020 | 21 | 916 | 4,547 | $454,363 | $170,142 |
Total Patients
3,055
Total Services
20,780
Medicare Billing
$707,208
Procedure Codes
70
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 18 | 4,024 | $523,120 | $104,742 | 20.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 249 | 525 | $181,125 | $56,263 | 31.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 33 | 3,060 | $102,000 | $54,878 | 53.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 25 | 118 | $46,492 | $14,264 | 30.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 35 | 111 | $21,534 | $6,515 | 30.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $17,433 | $5,578 | 32.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 30 | $14,550 | $4,563 | 31.4% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 25 | 173 | $14,186 | $4,411 | 31.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 17 | 19 | $6,555 | $2,092 | 31.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 50 | 126 | $4,914 | $1,571 | 32.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 57 | 105 | $1,365 | $882.00 | 64.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 46 | 82 | $2,624 | $848.70 | 32.3% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 14 | 52 | $2,340 | $727.16 | 31.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 42 | 83 | $3,569 | $631.63 | 17.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 13 | 14 | $1,190 | $406.14 | 34.1% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 34 | 72 | $1,728 | $365.76 | 21.2% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 12 | 17 | $680.00 | $160.28 | 23.6% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2023 | 28 | 42 | $1,218 | $111.30 | 9.1% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 11 | 30 | $240.00 | $24.65 | 10.3% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2022 | 18 | 1,970 | $256,100 | $55,598 | 21.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 251 | 493 | $170,085 | $50,828 | 29.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 23 | 1,680 | $57,120 | $29,002 | 50.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 56 | 56 | $25,032 | $7,202 | 28.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 21 | 45 | $17,730 | $5,845 | 33.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 26 | 70 | $13,580 | $4,480 | 33.0% |
About Dr. Simranjit Singh, MD
Dr. Simranjit Singh, MD is a Rheumatology healthcare provider based in Mission Viejo, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2014. The National Provider Identifier (NPI) number assigned to this provider is 1396164356.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Simranjit Singh, MD has received a total of $9,964 in payments from pharmaceutical and medical device companies, with $2,770 received in 2024. These payments were reported across 489 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($9,813).
As a Medicare-enrolled provider, Singh has provided services to 3,055 Medicare beneficiaries, totaling 20,780 services with total Medicare billing of $707,208. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Mission Viejo, CA
- Active Since 04/07/2014
- Last Updated 11/10/2021
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1396164356
Products in Payments
- Enbrel (Biological) $1,407
- RINVOQ (Biological) $1,308
- TALTZ (Drug) $775.52
- SKYRIZI (Biological) $737.19
- BENLYSTA (Biological) $549.86
- Cimzia (Drug) $529.54
- TREMFYA (Drug) $427.46
- Otezla (Drug) $418.89
- XELJANZ (Drug) $345.84
- COSENTYX (Drug) $323.53
- KRYSTEXXA (Biological) $307.04
- SAPHNELO (Biological) $234.89
- COSENTYX (Biological) $222.85
- EVENITY (Biological) $201.63
- OFEV (Drug) $140.57
- Rituxan (Biological) $136.58
- LUPKYNIS (Drug) $116.43
- Otezla (Biological) $114.51
- Tymlos (Biological) $88.03
- ORENCIA (Biological) $87.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Mission Viejo
Dr. Willilam Shiel, M.d, M.D
Rheumatology — Payments: $927,424
Rheumatology $927,424
Dr. Hernan Castro-Rueda, M.d, M.D
Rheumatology — Payments: $25,626
Rheumatology $25,626
Catherine Driver, M.d, M.D
Rheumatology — Payments: $19,339
Rheumatology $19,339
Dr. Fatemeh Jafari Farshami, M.d, M.D
Rheumatology — Payments: $4,323
Rheumatology $4,323
Dr. Paul Wehrle, M.d, M.D
Rheumatology — Payments: $257.06
Rheumatology $257.06